Real-World Experience with Dolutegravir-Based Two-Drug Regimens

BACKGROUND: Dolutegravir-based 2-drug regimens (DTG 2DRs) are now accepted as alternatives to 3-drug regimens for HIV antiretroviral treatment (ART); however, literature on physician drivers for prescribing DTG 2DR is sparse. This study evaluated treatment patterns of DTG 2DR components in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Ward, Douglas, Ramgopal, Moti, Riedel, David J., Garris, Cindy, Dhir, Shelly, Waller, John, Roberts, Jenna, Mycock, Katie, Oglesby, Alan, Collins, Bonnie, Dominguez, Megan, Pike, James, Mrus, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364229/
https://www.ncbi.nlm.nih.gov/pubmed/32724674
http://dx.doi.org/10.1155/2020/5923256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364229/
https://www.ncbi.nlm.nih.gov/pubmed/32724674
http://dx.doi.org/10.1155/2020/5923256

Ejemplares similares